Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 42

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 42
---
 Officer and Director |
| Margaret Ancona     |     |  55 |     | Senior Vice President, Chief of Staff              |
| Jennifer Fox        |     |  52 |     | Chief Legal Officer                                |
| Kevin R. Haas       |     |  40 |     | Chief Technology Officer                           |
| Scott J. Leffler(2) |     |  50 |     | Chief Financial Officer                            |
| Dale Muzzey         |     |  45 |     | Chief Scientific Officer                           |
| Sam S. Raha(3)      |     |  53 |     | Chief Operating Officer                            |
| Shereen Solaiman    |     |  52 |     | Chief People Officer                               |
| Mark Verratti(4)    |     |  56 |     | Chief Commercial Officer                           |

(1) Mr. Diaz announced that he will resign from his position as President and Chief Executive Officer effective April 30, 2025.

(2) Mr. Leffler was appointed Chief Financial Officer effective January 29, 2024.

(3) Mr. Raha will succeed Mr. Diaz as President and Chief Executive Officer effective April 30, 2025.

(4) Mr. Verratti will succeed Mr. Raha as Chief Operating Officer effective April 30, 2025.

| Paul J. Diaz                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |     |                                          |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |     | President and Chief Executive Officer(1) |
| Paul J. Diaz was appointed as the President and Chief Executive Officer, or CEO, of Myriad Genetics, Inc., and a member of the Board, effective August 13, 2020. Prior to joining Myriad, Mr. Diaz was a partner at Cressey & Company (2016-2020), a private investment firm headquartered in Chicago, Illinois, which at that time managed over $3.0 billion in committed capital. Cressey & Company is a healthcare focused middle-market private equity firm with over 30 years of success investing in and helping to build high quality healthcare businesses. Mr. Diaz is the former president and CEO and vice chairman of Kindred Healthcare, Inc. (2002-2016) then a Fortune 500 Company and one of the largest providers of healthcare services in the United States. At the time,